GSK (GSK) president acquires notional ADS under executive savings plan

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

GSK plc reported that President Maya Martinez-Davis acquired notional American Depositary Shares through a company savings plan. The transaction involved 9.4103 ADS at a price of $50.7400 per ADS on the New York Stock Exchange on 2026-06-22, within her GSK Executive Supplemental Savings Plan account.

Key Figures

ADS volume acquired: 9.4103 ADS ADS price: $50.7400 per ADS Transaction date: 2026-06-22 +1 more

4 metrics

ADS volume acquired 9.4103 ADS Notional ADS acquired by President in plan account

ADS price $50.7400 per ADS Price for the notional ADS acquisition

Transaction date 2026-06-22 Date of ADS acquisition on NYSE (XNYS)

Instrument identifier ISIN US37733W2044 American Depositary Shares of GSK plc

Key Terms

PDMR, American Depositary Shares, Executive Supplemental Savings Plan, LEI

4 terms

PDMR regulatory

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS')"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Executive Supplemental Savings Plan financial

"Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account"

LEI regulatory

"b) | LEI | 5493000HZTVUYLO1D793"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 6-K: How Foreign Companies Report to the SEC →

06/24/2026 - 10:46 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Maya Martinez-Davis
b)	Position/status	President, US
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.7400	9.4103

d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

	GSK plc
	(Registrant)

Date: June 24, 2026

	By:/s/ VICTORIA WHYTE --------------------------

	Victoria Whyte
	Authorised Signatory for and on
	behalf of GSK plc

  &#xD;  

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did GSK (GSK) disclose in this 6-K?

GSK disclosed that President Maya Martinez-Davis acquired notional American Depositary Shares. The transaction occurred within her GSK Executive Supplemental Savings Plan account, reflecting 9.4103 ADS at $50.7400 per ADS, and was reported as an initial notification for this acquisition.

Who is the GSK (GSK) executive involved in the reported transaction?

The executive is Maya Martinez-Davis, identified as President at GSK. She is classified as a PDMR, meaning a person discharging managerial responsibilities, and the filing records her acquisition of notional ADS in the GSK Executive Supplemental Savings Plan on the New York Stock Exchange.

What type of security did the GSK (GSK) executive acquire?

Maya Martinez-Davis acquired notional American Depositary Shares, or ADS, of GSK. These ADS are identified with ISIN US37733W2044 and were credited within her GSK Executive Supplemental Savings Plan account rather than through a standard open-market purchase transaction.

What were the price and volume in the GSK (GSK) executive’s ADS transaction?

The transaction covered 9.4103 notional American Depositary Shares at a price of $50.7400 per ADS. This is recorded as a single transaction in the filing, with no aggregation across multiple trades, and occurred on the New York Stock Exchange.

When and where did the GSK (GSK) ADS transaction take place?

The transaction took place on 2026-06-22 on the New York Stock Exchange, identified as XNYS. The filing specifies this as the trading venue where the notional ADS were acquired within the executive’s GSK Executive Supplemental Savings Plan account.

How is this GSK (GSK) insider transaction categorized in the filing?

The transaction is described as an acquisition of notional ADS within Maya Martinez-Davis’s GSK Executive Supplemental Savings Plan account. It is reported as an initial notification and relates to a person discharging managerial responsibilities, highlighting transparency around executive-linked share interests.